We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Several Senate Democrats have joined their Republican colleagues in a request that Senate leaders remove the “Preserve Access to Affordable Generics Act” (S. 369) from a fiscal year 2011 appropriations bill (S. 3677
The Federal Trade Commission (FTC) will conduct a public workshop on June 21, 2011, to present options aimed at preventing competition issues raised when patented technologies are incorporated in the standards developed by private, collaborative standard-setting organizations
The Federal Trade Commission has issued for public comment a notice of proposed rulemaking that is intended to clarify “when a transfer of exclusive rights to a patent in the pharmaceutical industry results in a potentially reportable asset acquisition under the Hart Scott Rodino (HSR) Act.”
